Literature DB >> 8238262

Feline immunodeficiency virus predisposes cats to acute generalized toxoplasmosis.

M G Davidson1, J B Rottman, R V English, M R Lappin, M B Tompkins.   

Abstract

This study was designed to examine the effects of a pre-existing, clinically asymptomatic feline immunodeficiency virus (FIV) infection on a primary challenge with Toxoplasma gondii. Parenteral challenge of FIV-infected cats with tachyzoites of the ME49 strain of T. gondii caused a precipitous drop in all lymphocytes (CD4+, CD8+, and B cells) and generalized severe toxoplasmosis. The predominant postmortem lesions included acute and often fatal interstitial pneumonia, dominated histologically by macrophages, and multifocal to coalescing hepatic necrosis. Immunohistochemistry revealed numerous T. gondii antigen and tachyzoites in macrophages and other cell types in the lung lesions. The proliferative response of peripheral blood mononuclear cells to specific (T. gondii antigen) and nonspecific (Concanavalin A) mitogens was defective in the dually infected cats, suggesting marked immunosuppression. In contrast to the dually infected cats, cats infected only with T. gondii developed a transient, mild clinical disease characterized by anorexia, lethargy, and multifocal chorioretinitis. Lymphocyte changes in T. gondii-infected cats included an early pan-lymphopenia followed by reestablishment of all lymphocyte subset profiles. These cats also showed a reduced proliferative response to Concanavalin A at 1 week after challenge, but a measurable in vivo response to T. gondii antigens, as evidenced by in vitro lymphocyte proliferation in the absence of a mitogenic stimulus. These results show that infection of cats with FIV-NCSU, markedly enhances their susceptibility to a primary T. gondii infection and provides a model to study the mechanisms of the underlying immunological defect(s) occurring early after HIV infection that may predispose individuals to development of acquired immunodeficiency syndrome and associated diseases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8238262      PMCID: PMC1887187     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

1.  The effect of anti-IFN-gamma antibody on the protective effect of Lyt-2+ immune T cells against toxoplasmosis in mice.

Authors:  Y Suzuki; J S Remington
Journal:  J Immunol       Date:  1990-03-01       Impact factor: 5.422

2.  Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.

Authors:  M Clerici; N I Stocks; R A Zajac; R N Boswell; D R Lucey; C S Via; G M Shearer
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

3.  Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice.

Authors:  Y Suzuki; J S Remington
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

4.  Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanism.

Authors:  C M Walker; A L Erickson; F C Hsueh; J A Levy
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

5.  Opportunistic infections and retrovirus-induced immunodeficiency: studies of acute and chronic infections with Toxoplasma gondii in mice infected with LP-BM5 murine leukemia viruses.

Authors:  R T Gazzinelli; J W Hartley; T N Fredrickson; S K Chattopadhyay; A Sher; H C Morse
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

6.  Pathophysiology of toxoplasmosis.

Authors:  J K Frenkel
Journal:  Parasitol Today       Date:  1988-10

7.  Immunological changes in cats with concurrent Toxoplasma gondii and feline immunodeficiency virus infections.

Authors:  D S Lin; D D Bowman; R H Jacobson
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

8.  Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome.

Authors:  B J Luft; R G Brooks; F K Conley; R E McCabe; J S Remington
Journal:  JAMA       Date:  1984-08-17       Impact factor: 56.272

9.  Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus.

Authors:  C D Ackley; J K Yamamoto; N Levy; N C Pedersen; M D Cooper
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

10.  Pathogenesis of acute toxoplasmosis in specific-pathogen-free cats.

Authors:  G A Parker; J M Langloss; J P Dubey; E A Hoover
Journal:  Vet Pathol       Date:  1981-11       Impact factor: 2.221

View more
  33 in total

1.  A serological survey of feline immunodeficiency virus and Toxoplasma gondii in stray cats.

Authors:  E D'Amore; E Falcone; L Busani; M Tollis
Journal:  Vet Res Commun       Date:  1997-07       Impact factor: 2.459

2.  Paradoxical effect of clindamycin in experimental, acute toxoplasmosis in cats.

Authors:  M G Davidson; M R Lappin; J R Rottman; M B Tompkins; R V English; A T Bruce; J Jayawickrama
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

3.  Molecularly cloned feline immunodeficiency virus NCSU1 JSY3 induces immunodeficiency in specific-pathogen-free cats.

Authors:  J S Yang; R V English; J W Ritchey; M G Davidson; T Wasmoen; J K Levy; D H Gebhard; M B Tompkins; W A Tompkins
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

Review 4.  Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors:  M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

5.  Evidence for CD8+ antiviral activity in cats infected with feline immunodeficiency virus.

Authors:  C R Jeng; R V English; T Childers; M B Tompkins; W A Tompkins
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

Review 6.  Lentivirus-induced immune dysregulation.

Authors:  Mary B Tompkins; Wayne A Tompkins
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

7.  Prior mucosal exposure to heterologous cells alters the pathogenesis of cell-associated mucosal feline immunodeficiency virus challenge.

Authors:  Surender B Kumar; Sarah Leavell; Kyle Porter; Barnabe D Assogba; Mary J Burkhard
Journal:  Retrovirology       Date:  2010-05-28       Impact factor: 4.602

8.  Acute toxoplasmosis and pox-viral dermatitis in a juvenile bald eagle (Haliaeetus leucocephalus) in New Brunswick, Canada.

Authors:  Laura Bourque; Spencer J Greenwood; Megan E B Jones
Journal:  Can Vet J       Date:  2020-08       Impact factor: 1.008

Review 9.  Immunopathogenesis of feline immunodeficiency virus infection in the fetal and neonatal cat.

Authors:  Holly M Kolenda-Roberts; Leah A Kuhnt; Ryan N Jennings; Ayalew Mergia; Nazareth Gengozian; Calvin M Johnson
Journal:  Front Biosci       Date:  2007-05-01

10.  CD8+ clonality is associated with prolonged acute plasma viremia and altered mRNA cytokine profiles during the course of feline immunodeficiency virus infection.

Authors:  Michelle M Miller; Elizabeth M Thompson; Steven E Suter; Jonathan E Fogle
Journal:  Vet Immunol Immunopathol       Date:  2012-12-20       Impact factor: 2.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.